Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 217

The DOI matches its Crossref record; 5 of the 5 references it cites were found in a registry or an index.

External validation of a prognostic CT-based radiomic signature in oropharyngeal squamous cell carcinoma

Open access
Leijenaar, Ralph T. H., Carvalho, Sara, Hoebers, Frank J. P., Aerts, Hugo J. W. L., van Elmpt, Wouter J. C., Huang, Shao Hui, Chan, Biu, Waldron, John N., O’sullivan, Brian, Lambin, Philippe·2015·Acta Oncologica

Abstract

BACKGROUND: Oropharyngeal squamous cell carcinoma (OPSCC) is one of the fastest growing disease sites of head and neck cancers. A recently described radiomic signature, based exclusively on pre-treatment computed tomography (CT) imaging of the primary tumor volume, was found to be prognostic in independent cohorts of lung and head and neck cancer patients treated in the Netherlands. Here, we further validate this signature in a large and independent North American cohort of OPSCC patients, also considering CT artifacts. METHODS: A total of 542 OPSCC patients were included for which we determined the prognostic index (PI) of the radiomic signature. We tested the signature model fit in a Cox regression and assessed model discrimination with Harrell's c-index. Kaplan-Meier survival curves between high and low signature predictions were compared with a log-rank test. Validation was performed in the complete cohort (PMH1) and in the subset of patients without (PMH2) and with (PMH3) visible CT artifacts within the delineated tumor region. RESULTS: We identified 267 (49%) patients without and 275 (51%) with visible CT artifacts. The calibration slope (β) on the PI in a Cox proportional hazards model was 1.27 (H0: β = 1, p = 0.152) in the PMH1 (n = 542), 0.855 (H0: β = 1, p = 0.524) in the PMH2 (n = 267) and 1.99 (H0: β = 1, p = 0.002) in the PMH3 (n = 275) cohort. Harrell's c-index was 0.628 (p = 2.72e-9), 0.634 (p = 2.7e-6) and 0.647 (p = 5.35e-6) for the PMH1, PMH2 and PMH3 cohort, respectively. Kaplan-Meier survival curves were significantly different (p < 0.05) between high and low radiomic signature model predictions for all cohorts. CONCLUSION: Overall, the signature validated well using all CT images as-is, demonstrating a good model fit and preservation of discrimination. Even though CT artifacts were shown to be of influence, the signature had significant prognostic power regardless if patients with CT artifacts were included.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.3109/0284186x.2015.1061214

Cites

5 of 5 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 5 references

Cited by

See all 217

Metadata

Authors
Leijenaar, R. T. H., Carvalho, S., Hoebers, F. J. P., Aerts, H. J. W. L., van Elmpt, W. J. C., Huang, S. H., Chan, B., Waldron, J. N., O’sullivan, B., & Lambin, P.
Venue
Acta Oncologica
Published
2015-08-12
Volume
54
Issue
9
Pages
1423-1429
ISSN
  • 0284-186X (ISSN-L)
  • 1651-226X
OpenAlex
W1824790222
Cited by
217
References
5
FWCI
16.50
Type
journal article
Language
en
Open access
diamond

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: External validation of a prognostic CT-based radiomic signature in oropharyngeal squamous cell carcinoma. https://app.cochat.ai/papers/10.3109/0284186x.2015.1061214
The paper
Leijenaar, R. T. H., Carvalho, S., Hoebers, F. J. P., Aerts, H. J. W. L., van Elmpt, W. J. C., Huang, S. H., Chan, B., Waldron, J. N., O’sullivan, B., & Lambin, P. (2015). External validation of a prognostic CT-based radiomic signature in oropharyngeal squamous cell carcinoma. Acta Oncologica. https://doi.org/10.3109/0284186x.2015.1061214

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.